Connect with us

Subscribe

Subscribe

News & Views

Patients can be investors in the hospitals that serve them: Socialized medicine within a specialized profit making institution

BY STEVEN KASZAB

Throughout Canada the Universal Healthcare system we all brag about has been challenged, stretched to a point of stressful breakage. It is failing many of us who have paid into an insurance system that cannot satisfy our health needs. Excuses are abundant, from: we do not have enough funds, to we do not have enough staff, or we do not have enough doctors, or surgeons to perform their tasks. Healthcare professionals are burnt out, living in a situation of constant stress, with a pressure-cooking atmosphere ready to pop.

What to do?

Rare disorders are only studied, and remedies found if it is profitable to the pharmaceutical firms in North America. 25% of rare disease patients wait 5 – 30 years for a diagnosis, while 40% are misdiagnosed. Only 5% of children with rare disorders have access to effective treatment. Walls of ignorance, economic blockage and fatalism face those caregivers of the ill. The financial and healthcare system (one relies upon the other) will not provide the needed funds to fix what genetics and evolution have inflicted upon us.

Idea: Let’s look at autism as an example of what to do.

People who care for autistic children often pay $1500 – $3,500.00 a month for therapy, and specialized schooling. Spending $40 – $60,000 annually is very common. What do these caregivers do when a child becomes an adult? There are no places to send them, and no funds available to protect both caregiver and patient. Autistic adults can be very difficult to handle, violent at times.

Well, since caregivers invest so much money into the care of their patients, how about getting them to invest in centers/hospitals that specialize in several rare diseases only. Who can say that a hospital that makes a profit is not a useful institution? Patients can be investors in the hospitals that serve them, as can all Ontarians/Canadians.

University students specializing in psychology and other medical pursuits would be required to work in such hospitals, receive real time education and get paid for their efforts too. Hospitals can be places of real lived experiences, fulfilling the medical and financial needs of patients and their caregivers also.

Universal Medicine cannot be everything to everybody, and rare diseases will remain after thoughts to both the medical and pharmaceutical industry so long as they remain just a few of the many needs out there in society.

Pharmaceutical companies can research and develop in real terms medicine specific to rare disease patients, while sharing in the hospitals profitability. The hospital partners can be the: provincial government, municipal government, pharmaceutical firms and corporations, and the patients families also. Average citizens can invest in these specialized centers, sharing in their healthcare successes.

It will be socialized medicine within a specialized profit making institution. No one turned away, or put onto a waiting list.

It is either this or those with rare diseases are truly sh*t out of luck.

Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

The Warnings We Ignored

Featured Cover Story

What It Means to Be a Lifelong Supporter: Larry Weltman on Loyalty, Community, and the Beautiful Game

Sports

Sharon Marley Reclaims Her Voice

Women Empowered

Toronto Collides Into New Culture

Entertainment

Advertisement
Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!

Legal and Advertising Disclaimer: Advertisements, sponsored content, business listings and other promotional materials are supplied by third parties. Their publication does not constitute an endorsement, recommendation, representation, warranty or guarantee by TCN Now Inc. Advertisers and content providers are responsible for the accuracy, legality and substantiation of their claims and for obtaining all necessary copyright, trademark, privacy and other permissions. To the fullest extent permitted by law, TCN Now Inc., its directors, officers, employees, contractors and affiliates shall not be liable for any loss, damage, cost, expense or claim arising from third-party advertisements, products, services or promotional content. TCN Now Inc. reserves the right to refuse, edit, suspend or remove advertising or promotional content at its discretion. Editorial and Content Disclaimer: The opinions, commentary and viewpoints expressed in signed articles, columns, letters, guest submissions and other contributor content belong to the respective authors and do not necessarily reflect the opinions or views of TCN Now Inc., its directors, officers, employees, editors or affiliates. Content published by TCN Now Inc. is provided for general informational purposes only and is not intended as legal, financial, medical or other professional advice. While reasonable efforts are made to ensure accuracy, TCN Now Inc. does not guarantee that all information will be complete, current or free from error. To the fullest extent permitted by law, TCN Now Inc. disclaims liability for losses or claims arising from reliance upon contributor opinions, third-party submissions or general informational content. Copyright © 2026 TCN Now Inc. All rights reserved. Unless otherwise stated, the text, photographs, graphics, logos, designs and other original content appearing on this website are owned by or licensed to TCN Now Inc. and may not be copied, reproduced, republished, distributed, modified or commercially used without prior written permission, except as otherwise permitted by law. Third-party names, logos, trademarks and content remain the property of their respective owners.

Connect
Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!